HCPCS Level IIdrugActive
J1961
Inj lenacapavir (hiv tx) 1mg
BETOS: O1E
Effective: 2025-06-18
Referenced in 1 policies
Description
Injection, lenacapavir (only for use as hiv treatment), 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Sunlenca
Manufacturer
Gilead Sciences, Inc.
HCPCS Dosage
1 MG
Billing Units
463.5000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.